Search

John P Parlow

from Saint Louis, MO
Age ~81

John Parlow Phones & Addresses

  • 2233 Viewroyal Dr, Saint Louis, MO 63131 (314) 822-9903
  • Des Peres, MO
  • Arnold, MO

Resumes

Resumes

John Parlow Photo 1

Senior Research Chemist And Science Fellow

View page
Location:
St, Louis, MO
Industry:
Research
Work:
Monsanto Company Apr 2012 - 2016
Senior Research Chemist and Science Fellow

Monsanto Company Jun 2010 - Apr 2012
Engagement Lead

Pfizer Apr 2003 - Apr 2010
Associate Research Fellow

Pfizer Apr 2000 - Apr 2003
Research Advisor and Associate Fellow

Monsanto Company Jun 1987 - Sep 1998
Chemical Methodology Team Leader
Education:
Miami University 1986 - 1987
Masters, Organic Chemistry
Miami University 1982 - 1985
Bachelors, Bachelor of Science, Chemistry
Vianney High School 1978 - 1982
Skills:
Drug Discovery
Lc Ms
Chemistry
Medicinal Chemistry
Purification
In Vivo
Hplc
Analytical Chemistry
Assay Development
Laboratory
Chromatography
Biotechnology
Organic Synthesis
Nmr
Lead Change
Life Sciences
Organic Chemistry
Synthetic Organic Chemistry
Inflammation
In Vitro
Drug Design
Biomarker Discovery
John Parlow Photo 2

Hvac And R Product Design And System Application Engineering, Sales Management, And Corporate Management

View page
Location:
Saint Louis, MO
Industry:
Mechanical Or Industrial Engineering
Education:
C.b.c. High School In St. Louis
Washington University In St. Louis
Bachelors, Bachelor of Science, Mechanical Engineering
Skills:
Rectabular Extrusion Transmogrifications
Kanute Valve Transarangical Analysis
P.s.i. Inflation/Discharge Proceedural Planning
Copperostic Attachment Strain Analysis
Magtometer and Tappet Modulator Implementations
Differentialator and Carburinjector Stiphalasuming
Ambihelical Hexnut Fabricatorism
Stationary Dynamic Rotationating Fixationismating
Nonsinusoidal Alternating Direct Phasor Reviews
Thermionic Regenerating Polyextractions
Kinematic Transfercation and Shrinkafier Corrections
Interests:
Cars * Guns * Sports * Travel * Fishing
John Parlow Photo 3

John Parlow

View page
John Parlow Photo 4

John Parlow

View page

Publications

Us Patents

Substituted Polycyclic Aryl And Heteroaryl Pyridines Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6624180, Sep 23, 2003
Filed:
Nov 20, 2001
Appl. No.:
09/989634
Inventors:
Michael J. South - St. Louis MO
Brenda Case - St. Louis MO
Danny J. Garland - Ballwin MO
Michael J. Hayes - St. Louis MO
Horng-Chih Huang - Chesterfield MO
Wei Huang - Wildwood MO
Darin E. Jones - Ballwin MO
William L. Neumann - St. Louis MO
John J. Parlow - Arnold MO
David B. Reitz - Chesterfield MO
Melvin L. Rueppel - St. Louis MO
Rondald K. Webber - St. Charles MO
Assignee:
Pharmacia Corporation - St. Louis MO
International Classification:
C07D21306
US Classification:
514352, 514242, 51425506, 514275, 546309, 544194, 544316, 544407
Abstract:
The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation cascade.

Polycyclic Aryl And Heteroaryl Substituted Benzenes Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6660885, Dec 9, 2003
Filed:
Mar 13, 2001
Appl. No.:
09/804959
Inventors:
Michael S. South - St. Louis MO
John J. Parlow - Arnold MO
Assignee:
Pharmacia Corporation - Skokie IL
International Classification:
C07C23305
US Classification:
564157, 564 92, 564168, 514331, 514335, 514400, 514604, 514616, 514619, 5443385, 546234, 546337
Abstract:
The invention relates to polycyclic aryl and heteroaryl substituted benzene compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.

Substituted Polycyclic Aryl And Heteroaryl Pyrazinones Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6664255, Dec 16, 2003
Filed:
May 18, 2000
Appl. No.:
09/574752
Inventors:
Michael South - St. Louis MO
John J. Parlow - Arnold MO
Darin E. Jones - Ballwin MO
Brenda Case - St. Louis MO
Tom Dice - St. Charles MO
Richard Lindmark - Kirkwood MO
Michael J. Hayes - St. Louis MO
Melvin L. Rueppel - St. Louis MO
Horng-Chih Huang - Chesterfield MO
Wei Huang - Wildwood MO
Scott A. Long - Ballwin MO
Matthew Mahoney - St. Peters MO
William L. Neumann - St. Louis MO
David Reitz - Chesterfield MO
John I. Trujillo - Creve Coeur MO
Ching-Cheng Wang - Wildwood MO
Rhonda Wood - Maryland Heights MO
Qingping Zeng - Ballwin MO
Rick Fenton - Collinsville IL
Gary W. Franklin - Godfrey IL
Carrie Kusturin - Edwardsville IL
Assignee:
Pharmacia Corporation - Chicago IL
International Classification:
C07D24120
US Classification:
5142358, 544405, 544237, 544295, 544120, 51425505, 514248
Abstract:
The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.

Polycyclic Aryl And Heteroaryl Substituted 1,4-Quinones Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6686484, Feb 3, 2004
Filed:
Apr 10, 2001
Appl. No.:
09/829739
Inventors:
Michael S. South - St. Louis MO
John J. Parlow - Arnold MO
Assignee:
Pharmacia Corporation - St. Louis MO
International Classification:
C07C 5004
US Classification:
552306
Abstract:
The invention relates to polycyclic aryl and heteroaryl substituted 1,4-quinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.

Substituted Polycyclic Aryl And Heteroaryl Pyridines Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6828338, Dec 7, 2004
Filed:
Jun 19, 2003
Appl. No.:
10/465125
Inventors:
Michael J. South - St. Louis MO
Brenda Case - St. Louis MO
Danny J. Garland - Ballwin MO
Michael J. Hayes - St. Louis MO
Horng-Chih Huang - Chesterfield MO
Wei Huang - Wildwood MO
Darin E. Jones - Ballwin MO
William L. Neumann - St. Louis MO
John J. Parlow - Arnold MO
David B. Reitz - Chesterfield MO
Melvin L. Rueppel - St. Louis MO
Rondald K. Webber - St. Charles MO
Assignee:
Pharmacia Corporation - St. Louis MO
International Classification:
A61K 3144
US Classification:
514352, 514242, 51425506, 514275, 546309, 544194, 544316, 544407
Abstract:
The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation cascade.

Polycyclic Aryl And Heteroaryl Substituted Benzenes Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6852761, Feb 8, 2005
Filed:
Mar 13, 2001
Appl. No.:
10/203866
Inventors:
Michael S. South - St. Louis MO, US
John J. Parlow - Arnold MO, US
Assignee:
Pharmacia Corporation - St. Louis MO
International Classification:
A61K031/155
C07C257/14
US Classification:
514637, 564 92, 564157, 564168, 564244, 564246
Abstract:
The invention relates to polycyclic aryl and heteroaryl substituted benzene compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.

Substituted Polycyclic Aryl And Heteroaryl Pyrazinones Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6908919, Jun 21, 2005
Filed:
Jul 15, 2002
Appl. No.:
10/195573
Inventors:
Michael S. South - St. Louis MO, US
Brenda L. Case - St. Louis MO, US
Thomas A. Dice - St. Charles MO, US
Ricky L. Fenton - Collinsville IL, US
Gary W. Franklin - Godfrey IL, US
Michael J. Hayes - St. Louis MO, US
Horng-Chih Huang - Chesterfield MO, US
Wei Huang - Wildwood MO, US
Darin E. Jones - Ballwin MO, US
Carrie L. Kusturin - Edwardsville IL, US
Richard J. Lindmark - St. Louis MO, US
Scott A. Long - Ballwin MO, US
William L. Neumann - St. Louis MO, US
David B. Reitz - Chesterfield MO, US
John I. Trujillo - St. Louis MO, US
Ching-Cheng Wang - Wildwood MO, US
Rhonda Wood - Maryland Heights MO, US
Qingping Zeng - Ballwin MO, US
Matthew W. Mahoney - St. Peters MO, US
John J. Parlow - Arnold MO, US
Melvin L. Rueppel - St. Louis MO, US
Assignee:
Pharmacia Corporation - Chicago IL
International Classification:
C07D241/20
C07D417/12
C07D401/12
A61K031/495
A61P007/02
US Classification:
5142358, 51425505, 514248, 544405, 544237, 544295, 544120
Abstract:
The invention relates to substituted polycyclic aryl and heteroaryl pyrazinone compounds useful as inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases.

6-Membered Heterocyclic Compounds Useful For Selective Inhibition Of The Coagulation Cascade

View page
US Patent:
6969715, Nov 29, 2005
Filed:
Oct 3, 2002
Appl. No.:
10/263637
Inventors:
Michael S. South - St. Louis MO, US
Ronald K. Webber - St. Charles MO, US
Horng-Chih Huang - Chesterfield MO, US
Mihaly V. Toth - St. Louis MO, US
Alan E. Moormann - Weldon Spring MO, US
Jeffery S. Snyder - Manchester MO, US
Jeffrey A. Scholten - Chesterfield MO, US
Danny J. Garland - Ballwin MO, US
Melvin L. Rueppel - St. Louis MO, US
William L. Neumann - St. Louis MO, US
Scott Long - Ballwin MO, US
Wei Huang - Wildwood MO, US
John Trujillo - St. Peters MO, US
John J. Parlow - Arnold MO, US
Darin E. Jones - Ballwin MO, US
Brenda Case - St. Louis MO, US
Michael J. Hayes - St. Louis MO, US
Assignee:
Pharmacia Corporation - St. Louis MO
International Classification:
C07D253/06
A61K031/53
A61P009/10
US Classification:
514242, 544182
Abstract:
The present invention relates to compounds, and prodrugs thereof, compositions and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation cascade.
John P Parlow from Saint Louis, MO, age ~81 Get Report